Open session Open full presentation page
Oral Presentation

“Self” reactive antibodies in paediatric living donor pairs: ANZKX perspective

Megan Kummrow
Presenter
Megan Kummrow (AU)

Senior Transplantation & Immunogenetics Scientist · Victorian Transplantation and Immunogenetics Service, Lifeblood · West Melbourne

Profile

Authors

Megan Kummrow1, Tim Emery2, Fiona Hudson1, Linda Cantwell1, Mary Diviney1

Affiliations

1 Australian Red Cross Lifeblood
2 Australian Red Cross Lifeblood, Adelaide

Abstract

Introduction: In the Australian and New Zealand Paired Kidney Exchange program (ANZKX), a cohort of paediatric renal transplant recipients from a range of centres presented with a similar HLA antibody profile (DRB1*04 and DRB1*09) commonly with self-reactive beads (DRB1*07). This investigation highlights the importance of differentiating between donor specific antibodies (DSA) and spurious antibody profiles to minimise wait time to transplant.
Method: A 3yo child and live donor were referred to a paediatric transplant centre for assessment. They had initially been determined as incompatible due to the presence of Class II donor specific antibodies (DSA). The pair were enrolled in the ANZKX program and the pool was reviewed for suitable matches. The pair were otherwise well matched and ABO compatible. As the source of the sensitisation to Class II was unknown, cell based assays including flow cytometric crossmatch and absorption and elution studies (AXE) were recommended. Over the following 2-year period, 7 additional paediatric cases have been identified in the ANZKX program that exhibited the same Class II antibody profile.
Results: The cell based assays for the primary case returned negative results indicating the reported DSA was not binding to intact antigen. Negative crossmatch results were replicated in two further cases. See results table (Figure 1) attached for further information. Upon further investigation, two recipients with the antibody profile were initially HLA antibody negative and became positive in subsequent testing. There was no allogenic sensitising event between the two time points however it was noted that multiple vaccinations were administered.

Figure 1
Figure 1. Summary of cases identified demonstrating similar antibody profile.

Conclusion: As HLA DSA are a barrier to transplantation, thorough investigation of Luminex antibody profiles is crucial in the absence of any obvious sensitising events or in the presence of self reacting beads. Accurate interpretation of Luminex antibody profiles paired with cell-based assays and eplet analysis is essential for identifying compatible donors and reducing wait-time to transplant. The presence of multiple paediatric transplant centres in Victoria has assisted the laboratory to more quickly identify the DRB1*04, DRB1*07, DRB1*09 phenomena. Visibility over a larger patient cohort such as those participating in ANZKX provides opportunities to identify recurrent spurious reactivity, not available to smaller laboratories. These profiles can then be referred to local units for further investigation.